For this analysis, the Japan Pulmonary Hypertension Registry provided data from 2008 to 2021 on patients with diagnosed portopulmonary hypertension (PoPH). Investigators found significant hemodynamic ...
Portopulmonary hypertension (PoPH) is a form of pulmonary arterial hypertension (PAH). PoPH occurs in approximately 15% of patients with PAH, and is reportedly found in 2-6% of patients with portal ...
Recent data suggest that the endothelin receptor antagonist macitentan can be used to target the endothelin pathway in patients with portopulmonary hypertension. SAN ANTONIO — In patients with ...
Portopulmonary hypertension (PoPH) is a form of pulmonary arterial hypertension (PAH). PoPH occurs in approximately 15% of patients with PAH, and is reportedly found in 2-6% of patients with portal ...
Please provide your email address to receive an email when new articles are posted on . Intrapulmonary vascular dilatations occurred more commonly in patients with portopulmonary hypertension and were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results